IRIX Pharmaceuticals

Pharmaceutical ManufacturingUnited States11-50 Employees

IRIX Pharmaceuticals is a privately held US-based pharmaceutical manufacturer that develops process technology for both new and existing drugs. It supplies active pharmaceutical ingredients and complex pharmaceutical intermediates from preclinical stages through all clinical phases, including registration/validation batches and ongoing commercial quantities. The company operates three sites dedicated to process development, clinical supply, and commercial production of APIs, with Florence handling process R&D and early-stage API supply and Greenville serving late-stage clinical supply and commercial production. IRIX adheres to regulatory and quality requirements, with FDA inspections of its Florence and Greenville sites in 2008 and 2009 resulting in no 483s. It functions as a contract resources and manufacturing organization for innovative pharmaceutical clients, offering seamless technology transfers for API synthesis and operating as an extension of a client's internal resources. This setup is intended to accelerate time to market and reduce costs for candidates moving from discovery to market, while the company operates from Florence and Greenville, South Carolina.

Sign up for free to view info

Email Format Employee directory